Short-term choroidal vascular changes after aflibercept therapy for neovascular age-related macular degeneration

被引：0
作者：
Marco Pellegrini
Federico Bernabei
Andrea Mercanti
Stefano Sebastiani
Enrico Peiretti
Claudio Iovino
Giamberto Casini
Pasquale Loiudice
Vincenzo Scorcia
Giuseppe Giannaccare
机构：
[1] University of Bologna,Ophthalmology Unit, S.Orsola
[2] Infermi Hospital,Malpighi University Hospital
[3] University of Cagliari,Ophthalmology Unit, Head and Neck Department of Ophthalmology
[4] Università degli Studi della Campania ‘Luigi Vanvitelli’,Department of Surgical Science, Eye Clinic
[5] University of Pisa,Eye Clinic, Multidisciplinary Department of Medical, Surgical and Dental Sciences
[6] University of “Magna Graecia”,Ophthalmology Unit, Department of Surgical, Medical, Molecular and Critical Area Pathology
来源：
Graefe's Archive for Clinical and Experimental Ophthalmology | 2021年 / 259卷
关键词：
Age-related macular degeneration; Anti-VEGF; Choroidal vascularity index; Optical coherence tomography;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：911 / 918
页数：7
相关论文
共 93 条
[1]  
Rosenfeld PJ(2006)Ranibizumab for neovascular age-related macular degeneration N Engl J Med 355 1419-1431
[2]  
Brown DM(2007)Ranibizumab inhibits multiple forms of biologically active vascular endothelial growth factor in vitro and in vivo Exp Eye Res 85 425-430
[3]  
Heier JS(2011)Ranibizumab and bevacizumab for neovascular age-related macular degeneration N Engl J Med 364 1897-1908
[4]  
Lowe J(2018)Anti-vascular endothelial growth factor for neovascular age-related macular degeneration: a meta-analysis of randomized controlled trials BMC Ophthalmol 18 130-1158
[5]  
Araujo J(2012)Aflibercept (VEGF trap-eye): The newest anti-VEGF drug Br J Ophthalmol 96 1157-2548
[6]  
Yang J(2012)Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration Ophthalmology 119 2537-1627
[7]  
Martin DF(2012)Subfoveal choroidal thickness after ranibizumab therapy for neovascular age-related macular degeneration: 12-month results Ophthalmology 119 1621-1702
[8]  
Maguire MG(2016)Comparison of intravitreal aflibercept and ranibizumab injections on subfoveal and peripapillary choroidal thickness in eyes with neovascular age-related macular degeneration Graefes Arch Clin Exp Ophthalmol 254 1693-362
[9]  
Ying GS(2015)Choroidal thickness changes after intravitreal antivascular endothelial growth factor therapy for age-related macular degeneration: ranibizumab versus aflibercept J Ocul Pharmacol Ther 31 357-633.e1
[10]  
Nguyen CL(2015)Short-term changes in choroidal thickness after aflibercept therapy for neovascular age-related macular degeneration Am J Ophthalmol 159 627-624
12345678910